Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4'-o-tetrahydropyranyladriamycin
2. 4'-o-tetrahydropyranyldoxorubicin
3. 4'-o-tetrapyranyldoxorubicin
4. Pirarubicin
5. Pirarubicin Hydrochloride
6. Thprubicine
7. Thepirubicin
8. Theprubicin
9. Thp-adm
10. Thp-adriamycin
11. Thp-dox
12. Thp-doxorubicin
1. Pirarubicin
2. 72496-41-4
3. Pinorubicin
4. Pinorubin
5. Pirarubicin, >=95% (hplc)
6. (7s,9s)-7-[(2r,4s,5s,6s)-4-amino-6-methyl-5-(oxan-2-yloxy)oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7h-tetracene-5,12-dione
7. Sr-01000944915
8. Sr-01000944915-1
Molecular Weight | 627.6 g/mol |
---|---|
Molecular Formula | C32H37NO12 |
XLogP3 | 2.7 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 7 |
Exact Mass | 627.23157562 g/mol |
Monoisotopic Mass | 627.23157562 g/mol |
Topological Polar Surface Area | 204 Ų |
Heavy Atom Count | 45 |
Formal Charge | 0 |
Complexity | 1120 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 6 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antineoplastic Agents
Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)
L - Antineoplastic and immunomodulating agents
L01 - Antineoplastic agents
L01D - Cytotoxic antibiotics and related substances
L01DB - Anthracyclines and related substances
L01DB08 - Pirarubicin
ABOUT THIS PAGE
73
PharmaCompass offers a list of Therarubicin Tn API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Therarubicin Tn manufacturer or Therarubicin Tn supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Therarubicin Tn manufacturer or Therarubicin Tn supplier.
PharmaCompass also assists you with knowing the Therarubicin Tn API Price utilized in the formulation of products. Therarubicin Tn API Price is not always fixed or binding as the Therarubicin Tn Price is obtained through a variety of data sources. The Therarubicin Tn Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Therarubicin Tn manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Therarubicin Tn, including repackagers and relabelers. The FDA regulates Therarubicin Tn manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Therarubicin Tn API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Therarubicin Tn supplier is an individual or a company that provides Therarubicin Tn active pharmaceutical ingredient (API) or Therarubicin Tn finished formulations upon request. The Therarubicin Tn suppliers may include Therarubicin Tn API manufacturers, exporters, distributors and traders.
click here to find a list of Therarubicin Tn suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Therarubicin Tn DMF (Drug Master File) is a document detailing the whole manufacturing process of Therarubicin Tn active pharmaceutical ingredient (API) in detail. Different forms of Therarubicin Tn DMFs exist exist since differing nations have different regulations, such as Therarubicin Tn USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Therarubicin Tn DMF submitted to regulatory agencies in the US is known as a USDMF. Therarubicin Tn USDMF includes data on Therarubicin Tn's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Therarubicin Tn USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Therarubicin Tn suppliers with USDMF on PharmaCompass.
Therarubicin Tn Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Therarubicin Tn GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Therarubicin Tn GMP manufacturer or Therarubicin Tn GMP API supplier for your needs.
A Therarubicin Tn CoA (Certificate of Analysis) is a formal document that attests to Therarubicin Tn's compliance with Therarubicin Tn specifications and serves as a tool for batch-level quality control.
Therarubicin Tn CoA mostly includes findings from lab analyses of a specific batch. For each Therarubicin Tn CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Therarubicin Tn may be tested according to a variety of international standards, such as European Pharmacopoeia (Therarubicin Tn EP), Therarubicin Tn JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Therarubicin Tn USP).